EXTREMITY EXPOSURE IN NUCLEAR MEDICINE: PRELIMINARY RESULTS OF A EUROPEAN STUDY
EXTREMITY EXPOSURE IN NUCLEAR MEDICINE: PRELIMINARY RESULTS OF A EUROPEAN STUDY
复制标题
DOI：
10.1093/rpd/ncq574
复制
发表时间：
2011-03-01
影响因子：
1
通讯作者：
Baechler, S.
中科院分区：
文献类型：
--
作者：
Merce, M. Sans;Ruiz, N.;Baechler, S.
ORAMED项目的工作包4是欧盟委员会在其第七个框架计划范围内支持的一个合作项目（2008-11年），涉及核医学医务人员肢体剂量测定的优化。为了评估在核医学部门工作的医务人员手中的极端剂量和剂量分布，欧洲32个核医学部门开始了广泛的测量计划。这是使用标准协议完成的，该协议记录了辐射暴露的所有相关信息，即辐射防护设备和工具。本研究显示了本次测量活动取得的初步结果。为了诊断的目的，考虑了两种最常用的放射性核素：Tc-99 m和F-18。对于治疗性处理，选择Zevalin（R）和DOTATOC（均用Y-90标记）。根据不同的参数，观察到双手之间的剂量差异很大。此外，这项研究强调了肢体剂量计的定位的重要性，以正确估计最大皮肤剂量。
The Work Package 4 of the ORAMED project, a collaborative project (2008-11) supported by the European Commission within its seventh Framework Programme, is concerned with the optimisation of the extremity dosimetry of medical staff in nuclear medicine. To evaluate the extremity doses and dose distributions across the hands of medical staff working in nuclear medicine departments, an extensive measurement programme has been started in 32 nuclear medicine departments in Europe. This was done using a standard protocol recording all relevant information for radiation exposure, i.e. radiation protection devices and tools. This study shows the preliminary results obtained for this measurement campaign. For diagnostic purposes, the two most-used radionuclides were considered: Tc-99m and F-18. For therapeutic treatments, Zevalin(R) and DOTATOC (both labelled with Y-90) were chosen. Large variations of doses were observed across the hands depending on different parameters. Furthermore, this study highlights the importance of the positioning of the extremity dosemeter for a correct estimate of the maximum skin doses.